Recent Posts
- Padagis Announces the FDA Approval and Launch of an AB Rated Generic Version of Tobradex® Ophthalmic Suspension
- Padagis Announces the First-to-Market Launch of an AB Rated Generic Version Of Zomig® Nasal Spray
- Padagis Announces The FDA Approval And Launch Of An AB Rated Generic Version Of Doxil® (Doxorubicin Liposome Injection)
- Padagis Announces The FDA Approval And Launch Of An AB Rated Generic Version Of Doxil® (Doxorubicin Liposome Injection)
- Padagis Confirms First-to-File Patent Challenge For Generic Version Of Eucrisa®
Recent Comments